Skip to main content

Table 1 Patient characteristics at baseline in the two groups

From: Does moderate-to-high intensity Nordic walking improve functional capacity and pain in fibromyalgia? A prospective randomized controlled trial

 

Nordic Walking n= 34

Low intensive Walking n= 33

 
 

Mean ± SD

Mean ± SD

P-value

Age, years

48 ± 7.8

50 ± 7.6

0.189

Symptom duration, years

11 ± 5.4

12 ± 5.3

0.436

Pain localisation, 0 to 18

14 ± 3.1

14 ± 2.7

0.548

TP, n

15 ± 1.8

15 ± 2.2

0.554

Algometer, kPa/sec

196 ± 56.0

210 ± 64.6

0.437

LTPAI, h

5.6 ± 4.6

4.8 ± 4.3

0.270

BMI

28 ± 4.0

28 ± 4.5

0.990

HAD-A

9.8 ± 5.3

7.2 ± 4.2

0.040

HAD-D

7.6 ± 4.3

6.8 ± 3.9

0.372

 

n (%)

n (%)

 

Pharmacological treatment

   

   Analgesics, yes

28 (82%)

27 (82%)

1.000

   Antidepressants/sedatives, yes

24 (70%)

21 (64%)

0.433

   Beta blocks, yes

4 (12%)

3 (9%)

0.517

Education, years

   

   ≤ 9

3 (9%)

10 (30%)

 

   10 to 12

18 (53%)

11 (33%)

 

   >12

13 (38%)

12 (36%)

1.195

Work status

   

   100 to 80%

8 (24%)

4 (12%)

 

   79 to 50%

8 (24%)

11 (33%)

 

   <50%

3 (9%)

4 (12%)

 

   Not working

15 (44%)

14 (42%)

0.696

Sick-leave

   

   None

31 (91%)

30 (91%)

 

   25 to 75%

1 (3%)

3 (9%)

 

   100%

2 (6%)

0 (0%)

0.574

Sick- or disability pension

   

   None

13 (38%)

7 (21%)

 

   25 to 75%

8 (24%)

13 (39%)

 

   100%

13 (38%)

13 (40%)

0.370

  1. P-values for the differences between the groups are given.
  2. TP, tender point, LTPAI, Leisure Time Physical Activity Instrument, BMI, body mass index, HAD-A, Hospital Anxiety and Depression - Anxiety, HAD-D, Hospital Anxiety and Depression - Depression, SD, standard deviation.